Biotech Values

[Biowatch]

trial sites

It could be that Levitt doesn't want investors badgering the clinicians and patients involved in the trials. I believe the investment company Sterling was fined by the SEC for having one of their people enroll in a clinical trial under false pretenses. (Although, admittedly, one couldn't fake AMD.) And, haven't some of us complained when certain reporters have quoted (unnamed) doctors involved in clinical trials when commenting on biotech stocks?

Two trials are listed at clinicaltrials.gov, but it does not give the locations.

http://www.clinicaltrials.gov/ct/gui/show/NCT00094120
MSI-1256F (Squalamine Lactate) in Combination with Verteporfin in Patients with "Wet" Age-Related Macular Degeneration (AMD)

Expected Total Enrollment:  60
Study start: October 2004


http://www.clinicaltrials.gov/ct/gui/show/NCT00089830
A Safety and Efficacy Study of MSI-1256F-209 (Squalamine Lactate) To Treat "Wet" Age-Related Macular Degeneration

Expected Total Enrollment:  120
Study start: August 2004;  Study completion: November 2004